4//SEC Filing
Kerr Giles Francis Bertram 4
Accession 0001104659-18-042321
CIK 0001621227other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 5:00 PM ET
Size
5.5 KB
Accession
0001104659-18-042321
Insider Transaction Report
Form 4
Kerr Giles Francis Bertram
Director
Transactions
- Award
Option to purchase Ordinary Shares
2018-06-22+124,000→ 124,000 totalExercise: $2.18From: 2019-06-22Exp: 2028-06-22→ Ordinary Shares (124,000 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP1.65 based on an exchange rate of $U.S. 1.3250 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001689112
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 5:00 PM ET
- Size
- 5.5 KB